National Bank Of Canada Atai Life Sciences N.V. Transaction History
National Bank Of Canada
- $73.7 Billion
- Q4 2024
A detailed history of National Bank Of Canada transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, National Bank Of Canada holds 737 shares of ATAI stock, worth $1,068. This represents 0.0% of its overall portfolio holdings.
Number of Shares
737
Previous 737
-0.0%
Holding current value
$1,068
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ATAI
# of Institutions
104Shares Held
16.3MCall Options Held
367KPut Options Held
69.2K-
Morgan Stanley New York, NY3.33MShares$4.83 Million0.0% of portfolio
-
Ubs Group Ag1.94MShares$2.81 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$1.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny982KShares$1.42 Million0.0% of portfolio
-
Davidson Kempner Capital Management LP New York, NY949KShares$1.38 Million0.03% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $241M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...